Methoxisopropamine

MXiPr (Methoxisopropamine, Isopropyloxetamine) is a recreational designer drug with dissociative effects. It is an arylcyclohexylamine derivative, related to drugs such as ketamine and methoxetamine. It was first identified in Slovenia in December 2020,[1] and was made illegal in Hungary in April 2021.[2]

MXiPr
Legal status
Legal status
Identifiers
  • 2-(isopropylamino)-2-(3-methoxyphenyl)cyclohexan-1-one
PubChem CID
Chemical and physical data
FormulaC16H23NO2
Molar mass261.365 g·mol−1
3D model (JSmol)
  • CC(C)NC1(CCCCC1=O)c1cccc(OC)c1
  • InChI=1S/C16H23NO2/c1-12(2)17-16(10-5-4-9-15(16)18)13-7-6-8-14(11-13)19-3/h6-8,11-12,17H,4-5,9-10H2,1-3H3
  • Key:FTQIVDGNGXPEKP-UHFFFAOYSA-N

See also

References
  1. "Analytical Report for MXiPr" (PDF). National Forensic Laboratory, Police, Ministry of the Interior. Republic of Slovenia. (2‐(3‐methoxyphenyl)‐2‐[(propan‐2‐yl)amino]cyclohexan‐1‐one C16H23NO2)
  2. "Amendment of Decree No 55/2014 of 30 December 2014 on substances or groups of compounds classified as new psychoactive substances". Minister for Human Capacities. Government of Hungary. 2021/225/HU.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.